We focus on upgrading pharmaceutical excipient performance and adapting to new drug dosage forms. Our R&D team collaborates with universities and pharmaceutical firms to develop low-residue, high-compatibility products (e.g., modified Lactose for biopharmaceuticals). We hold 15+ patents for excipient synthesis and formulation, driving industry progress while supporting clients’ new drug R&D.
